Latest Administration News

Page 67 of 164
Gold Mountain Limited has announced a fully underwritten $1.5 million entitlement offer alongside a $2 million placement to accelerate exploration activities in Brazil and Papua New Guinea. The capital raising, discounted by 40% to recent share prices, is underwritten by major shareholder José Luis Manzano, who may increase his stake to nearly 20%.
Maxwell Dee
Maxwell Dee
29 Sept 2025
Island Pharmaceuticals has submitted a detailed briefing to the FDA aiming to accelerate approval of its antiviral Galidesivir for Marburg virus under the Animal Rule, with feedback expected by November.
Victor Sage
Victor Sage
29 Sept 2025
Bravura Solutions has appointed Colin Greenhill as its new Group CEO, effective 1 January 2026, following a comprehensive global search. Greenhill brings over 15 years of leadership experience in financial services software, signaling a strategic step forward for the company.
Sophie Babbage
Sophie Babbage
29 Sept 2025
Super Retail Group Limited has updated its dividend details, confirming a fully franked ordinary dividend of AUD 0.34 per share and a special dividend of AUD 0.30 per share, alongside an updated dividend reinvestment plan price of AUD 16.90.
Logan Eniac
Logan Eniac
26 Sept 2025
Bod Science Limited has reported a notable profit turnaround for FY2025, driven by medicinal cannabis sales growth, while navigating a complex Deed of Company Arrangement and a proposed backdoor listing with Biortica Agrimed Limited.
Ada Torres
Ada Torres
26 Sept 2025
XRF Scientific Limited has confirmed its fully franked ordinary dividend for the 2025 financial year and updated details of its Dividend Reinvestment Plan price, offering shareholders a clear view on income and reinvestment options.
Ada Torres
Ada Torres
26 Sept 2025
Manuka Resources has received a binding debt offer to refinance existing obligations and support the restart of its Wonawinta silver and gold processing plant in early 2026, leveraging current high metal prices.
Maxwell Dee
Maxwell Dee
26 Sept 2025
Metro Finance 2021-1 Trust’s $652 million Class A Notes have been suspended from trading and removed from the ASX Official List following their redemption last November.
Claire Turing
Claire Turing
23 Sept 2025
Arovella Therapeutics has received a $3.21 million R&D tax incentive refund, bolstering its financial position as it prepares to initiate first-in-human trials for its lead cell therapy, ALA-101.
Ada Torres
Ada Torres
23 Sept 2025
Algorae Pharmaceuticals has secured an exclusive licensing agreement with Sakar Healthcare to introduce five generic oncology medicines in Australia and New Zealand, marking its first commercial foray in the region.
Victor Sage
Victor Sage
23 Sept 2025
The European Medicines Agency has approved continuous bi-monthly dosing of CLINUVEL’s SCENESSE® for adult erythropoietic protoporphyria patients, removing previous annual dose limits and aligning Europe with US treatment standards.
Victor Sage
Victor Sage
23 Sept 2025
Domino’s Pizza Enterprises has updated its dividend announcement to include a DRP price of AUD 14.26 with a 1% discount, alongside an unfranked dividend of AUD 0.215 per share for the half-year ending June 2025.
Victor Sage
Victor Sage
22 Sept 2025